Skip to main content

Advertisement

SpringerLink
Log in

Iron in neurodegenerative disorders

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Increasing evidence implicates a role of iron in the pathogenesis of numerous neurodegenerative diseases due to its capacity to enhance production of toxic reactive radicals and to induce protein aggregation. The underlying mechanism of iron accumulation in areas of the brain specific for the respective disease, however, is still unknown. Recent molecular and biochemical studies provide now insights into the consequences of impairment of brain iron metabolism. This review summarizes our understanding of the regulation of iron in the brain and defines the current knowledge on the involvement of iron metabolism in neurodegenerative diseases with genetically determined iron accumulation in the brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abboud, S. and Haile, D.J. (2000) “A novel mammalian iron-regulated protein involved in intracellular iron metabolism”, J. Biol. Chem. 26, 19906–19912.

    Article  Google Scholar 

  • Adamec, J., Rusnak, F., Owen, W.G., Naylor, S., Benson, L.M., Gacy, A.M. and Isaya, G. (2000) “Iron dependent self-assembly of recombinant yeast frataxin. Implications for Friedreich Ataxia”, Am. J. Hum. Genet. 67, 549–562.

    Article  PubMed  CAS  Google Scholar 

  • Aisen, P., Wessling-Resnick, M. and Leibold, E.A. (1999) “Iron metabolism”, Curr. Opin. Chem. Biol. 3, 200–206.

    Article  PubMed  CAS  Google Scholar 

  • Aisen, P., Enns, C. and Wessling-Resnick, M. (2001) “Chemistry and biology of eukaryotic iron metabolism”, Int. J. Biochem. Cell Biol. 33, 940–959.

    Article  PubMed  CAS  Google Scholar 

  • Allikmets, R., Raskind, W.H., Hutchinson, A., Schueck, N.D., Dean, M. and Koeller, D.M. (1999) “Mutation of a putative mitochondrial iron tranpsorter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A)”, Hum. Mol. Genet. 8, 743–749.

    Article  PubMed  CAS  Google Scholar 

  • Arawaka, S., Saito, Y., Murayma, S. and Mori, H. (1998) “Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein”, Neurology 51, 887–889.

    PubMed  CAS  Google Scholar 

  • Arima, K., Ueda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H. and Kawai, M. (1998) “NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmatic inclusions in the pontine nuclei in multiple system atrophy”, Acta Neuropathol. (Berl.) 96, 439–444.

    Article  CAS  Google Scholar 

  • Arosio, P., Levi, S., Santambrogio, P., Cozzi, A., Luzaggo, A., Cesareni, G. and Albertini, A. (1991) “Structural and functional studies of human ferritin H and L chains”, In: Lenfant, A.A., Manucci, C.L. and Sixma, P.M., eds, Biotechnology of Plasma Proteins, (Karger, Basel), pp. 127–131.

    Google Scholar 

  • Askwith, C. and Kaplan, J. (1998) “Iron and copper transport in yeast and its relevance to human disease”, TIBS 23, 135–138.

    PubMed  CAS  Google Scholar 

  • Attieh, Z.K., Mukhopadhyay, C.K., Seshadri, V., Tripoulas, N.A. and Fox, P.L. (1999) “Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism”, J. Biol. Chem. 274, 1116–1123.

    Article  PubMed  CAS  Google Scholar 

  • Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M. and Kaplan, J. (1997) “Regulation of mitochondrial iron accumulation by Yfh1, a putative h Yfh1pmolg of frataxin”, Science 276, 1709–1712.

    Article  PubMed  CAS  Google Scholar 

  • Bartzokis, G. and Tishler, T.A. (2000) “MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer’s and Huntington’s disease”, Cell Mol. Biol. 46, 821–833.

    PubMed  CAS  Google Scholar 

  • Bartzokis, G., Cummings, J., Perlman, S., Hance, D.B. and Mintz, J. (1999) “Increased basal ganglia iron levels in Huntington disease”, Arch. Neurol. 56, 569–574.

    Article  PubMed  CAS  Google Scholar 

  • Bartzokis, G., Sultzer, D., Cummings, J., Holt, L.E., Hance, D.B., Henderson, V.W. and Mintz, J. (2000) “In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging”, Arch. Gen. Psychiatry 57, 47–53.

    Article  PubMed  CAS  Google Scholar 

  • Beal, M.F. (1998) “Mitochondrial dysfunction in neurodegenerative diseases”, Biochim. Biophys. Acta 1366, 211–223.

    Article  PubMed  CAS  Google Scholar 

  • Becker, E. and Des Richardson, R. (2001) “Frataxin: its role in iron metabolism and the pathogenesis of Friendreich’s ataxia”, Int. J. Biochem. Cell Biol. 33, 1–10.

    Article  PubMed  CAS  Google Scholar 

  • Becker, G., Seufert, J., Bogdahn, U., Reichmann, H. and Reiners, K. (1995) “Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography”, Neurology 45, 182–184.

    PubMed  CAS  Google Scholar 

  • Bekri, S., Kispal, G., Lange, H., Fitzsimons, E., Tolmie, J., Lill, R. and Bishop, D.F. (2000) “Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation”, Blood 96, 3256–3264.

    PubMed  CAS  Google Scholar 

  • Ben-Shachar, D., Riederer, P. and Youdim, M.B. (1991) “Iron-melanin interaction and lipid peroxidation: implications for Parkinson’s disease”, J. Neurochem. 57, 1609–1614.

    Article  PubMed  CAS  Google Scholar 

  • Berg, D., Becker, G., Zeiler, B., Tucha, O., Hofmann, E., Preier, M., Benz, P., Jost, W., Reiners, K. and Lange, K.W. (1999) “Vulnerability of the nigrostriatal system as detected by transcranial ultrasound”, Neurology 53, 1026–1031.

    PubMed  CAS  Google Scholar 

  • Berg, D., Hoggenmüller, U., Hoffmann, E., Fischer, R., Kraus, M., Scheurlen, M. and Becker, G. (2000) “The basal ganglia in haemochromatosis”, Neuroradiology 42, 9–13.

    Article  PubMed  CAS  Google Scholar 

  • Berg, D., Siefker, C. and Becker, G. (2001a) “Substantia nigra hyperechogenicity on transcranial ultrasound—state marker for Parkison’s disease and impact on disease course”, J. Neurol. 248, 684–689.

    Article  PubMed  CAS  Google Scholar 

  • Berg, D., Gerlach, M., Youdim, M.B.H., Doulbe, K.L., Zecca, L., Riederer, P. and Becker, G. (2001b) “Brain iron pathways and their relevance to Parkinson’s disease”, J. Neurochem. 79, 225–236.

    Article  PubMed  CAS  Google Scholar 

  • Berg, D., Roggendorf, W., Schroder, U., Klein, R., Tatschner, T., Benz, P., Tucha, O., Preier, M., Lange, K.W., Reiners, K., Gerlach, M. and Becker, G. (2002) “Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury”, Arch. Neurol. 59, 999–1005.

    Article  PubMed  Google Scholar 

  • Boldt, D.H. (1999) “New perspectives on iron: an introduction”, Am. J. Med. Sci. 318, 207–212.

    Article  PubMed  CAS  Google Scholar 

  • Boll, M.-C., Sotelo, J., Otero, E., Alcaraz-Zubeldia, M. and Rios, C. (1999) “Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson’s disease”, Neurosci. Lett. 265, 155–158.

    Article  PubMed  CAS  Google Scholar 

  • Bonilla, E., Estevez, J., Suarez, H., Morales, L.M., de Bonilla, L.C., Villalobos, R. and Davila, J.O. (1991) “Serum ferritin in Huntington’s disease patients”, Neurosci. Lett. 129, 22–24.

    Article  PubMed  CAS  Google Scholar 

  • Bost, M., Berkaw, M., McBride, O.W., Chazot, G. and Arnaud, P. (1995) “Restriction polymorphisms of the ceruloplasmin gene on chromosome 3”, Hum. Genet. 96, 239–240.

    Article  PubMed  CAS  Google Scholar 

  • Bradbury, M.W.B. (1997) “Transport of iron in the blood-brain-cerebrospinal fluid system”, J. Neurochem. 69, 443–454.

    Article  PubMed  CAS  Google Scholar 

  • Bradley, J.L., Blake, J.C., Chamberlain, S., Thomas, P.K., Cooper, J.M. and Schapira, A.H. (2000) “Clinical, biochemical and molecular genetic correlations in Friedreich’s ataxia”, Hum. Mol. Genet. 9, 275–282.

    Article  PubMed  CAS  Google Scholar 

  • Brown, R.H. and Robberecht, W. (2001) “Amyotrophic lateral sclerosis: pathogenesis”, Semin. Neurol. 21, 131–139.

    Article  PubMed  Google Scholar 

  • Bruyn, G.W. (1968) “Huntington’s chorea: historical, clinical, and laboratory analysis”, In: Vinken, P.J. and Bruyn, G.W., eds, Handbook of Clinical Neurology Vol. 6, pp. 379–396.

  • Burdo, J.R., Martin, J., Menzies, S.L., Dolan, K.G., Romano, M.A., Fletcher, R.J., Garrick, M.D., Garrick, L.M. and Connor, J.R. (1999) “Cellular distribution of iron in the brain of the Belgrade rat”, Neuroscience 93, 1189–1196.

    Article  PubMed  CAS  Google Scholar 

  • Bush, A.I. and Goldstein, L.E. (2001) “Specific metal-catalysed protein reactions in chronic degenerative disorders of ageing: focus on Alzheimer’s disease and age-related cataracts”, Novartis Found. Symp. 235, 26–43.

    Article  PubMed  CAS  Google Scholar 

  • Cairo, G., Rappocciolo, E., Tacchini, L. and Schiaffonati, L. (1991) “Expression of genes for the ferritin H and L subunits in rat liver and heart”, Biochem. J. 275, 813–816.

    PubMed  CAS  Google Scholar 

  • Campuzano, V., Montermini, L., Molto, M.D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al., (1996) “Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion”, Science 271, 1423–1427.

    Article  PubMed  CAS  Google Scholar 

  • Campuzano, V., Montermini, L., Lutz, Y., et al., (1997) “Frataxin is reduced in Friedreich’s ataxia patients and is associated with mitochondrial membranes”, Hum. Mol. Genet. 61, 1771–1780.

    Article  Google Scholar 

  • Castellani, R.J., Smith, M.A., Nunomura, A., Harris, P.L. and Perry, G. (1999) “Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?” Free Radic. Biol. Med., 26, 1508–1512.

    Article  PubMed  CAS  Google Scholar 

  • Chen, J.C., Hardy, P.A., Kucharczyk, W., Clauberg, M., Joshi, J.G., Vourlas, A., Dhar, M. and Henkelman, R.M. (1993) “MR and human postmortem brain tissue: correlation between T2 and assays of iron and ferritin in Parkinson and Huntington disease”, AJNR 14, 275–281.

    PubMed  CAS  Google Scholar 

  • Chiueh, C.C. (2001) “Iron overload, oxidative stress, and axonal dystrophy in brain disorders”, Pediatr. Neurol. 25, 138–147.

    Article  PubMed  CAS  Google Scholar 

  • Cluskey, S. and Ramsden, D.B. (2001) “Mechanisms of neurodegeneration in amyotrophic lateral sclerosis”, J. Clin. Pathol.: Mol. Pathol. 54, 386–392.

    CAS  Google Scholar 

  • Coffey, C.E., Alston, S., Heinz, E.R. and Burger, P.C. (1989) “Brain iron in progressive supranuclear palsy: clinical, magnetic resonance imaging, and neuropathological findings”, J. Neuropsychiatry Clin. Neurosci. 1, 400–404.

    PubMed  CAS  Google Scholar 

  • Connor, J. (1997) “Evidence for iron mismanagement in the brain in neurological disorders”, In: Connor, J., ed. Metals and Oxidative Damage in Neurological Disorders (Plenum Press, New York), pp. 23–39.

    Google Scholar 

  • Connor, J.R. and Benkovic, S.A. (1992) “Iron regulation in the brain: histochemical, biochemical, and molecular considerations”, Ann. Neurol. 32, S51-S61.

    Article  PubMed  CAS  Google Scholar 

  • Connor, J.R., Snyder, B.S., Beard, J.L., Fine, R.E. and Mufson, E.J. (1992) “The regional distribution of iron and iron regulatory proteins in the brain in aging and Alzheimer’s disease”, J. Neurosci. Res. 31, 327–335.

    Article  PubMed  CAS  Google Scholar 

  • Cornett, C.R., Markesbery, W.R. and Ehmann, W.D. (1998) “Imbalances of trace elements related to oxidative damage in Alzheimer’s disease brain”, Neurotoxicology 19, 339–345.

    PubMed  CAS  Google Scholar 

  • Cossee, M., Campuzano, V., Koutnikova, H., Fischbeck, K., Mandel, J.L., Koenig, M., Bidichandani, S.I., Patel, P.I., Molte, M.D., Canizares, J., De Frutos, R., Pianese, L., Cavalcanti, F., Monticelli, A., Cocozza, S., Montermini, L. and Pandolfo, M. (1997) “Frataxin fracas”, Nat. Genet. 15, 337–338.

    Article  PubMed  CAS  Google Scholar 

  • Cossee, M., Durr, A., Schmitt, M., Dahl, N., Trouillas, P., Allinson, P., Kostrzewa, M., Nivelon-Chevallier, A., Gustavson, K.H., Kohlschutter, A., Muller, U., Mandel, J.L., Brice, A., Koenig, M., Cavalcanti, F., Tammaro, A., De Michele, G., Filla, A., Cocozza, S., Labuda, M., Montermini, L., Poirier, J. and Pandolfo, M. (1999) “Friedreich’s ataxia: point mutations and clinical presentation of compound heterozygotes”, Ann. Neurol. 45, 200–206.

    Article  PubMed  CAS  Google Scholar 

  • Csere, P., Lill, R. and Kispal, G. (1998) “Identification of a human mitochondrial ABC transporter, the functional orthologue of yeast Atm1p”, FEBS Lett. 441, 266–270.

    Article  PubMed  CAS  Google Scholar 

  • Curtis, A.R.J., Fey, C., Morris, C.M., Bindoff, L.A., Ince, P.G., Chinnery, P.F., Coulthard, A., Jackson, M.J., Jackson, A.P., McHale, D.P., Hay, D., Barker, W.A., Markham, A.F., Bates, D., Curtis, A. and Burn, J. (2001) “Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease”, Nat. Genet. 28, 350–354.

    Article  PubMed  CAS  Google Scholar 

  • Daimon, M., Yamatani, K., Igarashi, M., Fukase, N., Kawanami, T., Kato, T., Tominaga, M. and Sasaki, H. (1995a) “Fine structure of the human ceruloplasmin gene”, Biochem. Biophys. Res. Commun. 208, 1028–1035.

    Article  PubMed  CAS  Google Scholar 

  • Daimon, M., Morita, Y., Yamatani, K., Igarashi, M., Fukase, N., Kawanami, T., Kato, T., Tominaga, M. and Sasaki, H. (1995b) “Dinucleotide repeat polymorphism in the human ceruloplasmin gene”, Hum. Genet. 96, 736.

    Article  PubMed  CAS  Google Scholar 

  • De Castro, M., Garcia-Planells, J., Monros, E., Canizares, J., Vazquez-Manrique, R., Vilchez, J.J., Urtasun, M., Lucas, M., Navarro, G., Izquierdo, G., Molto, M.D. and Palau, F. (2000) “Genotype and phenotype analysis of Friedreich’s ataxia compound heterozygous patients”, Hum. Genet. 106, 86–92.

    Article  PubMed  Google Scholar 

  • Dean, M. and Allikmets, R. (1995) “Evolution of ATP-binding cassette transporter genes”, Curr. Opin. Genet. Dev. 5, 779–785.

    Article  PubMed  CAS  Google Scholar 

  • Deibel, M.A., Ehmann, W.D. and Markesbery, W.R. (1996) “Copper, iron, and zinc imbalances in severely degenerated bran regions in Alzheimer’s disease: possible relation to oxidative stress”, J. Neurol. Sci. 143, 137–142.

    Article  PubMed  CAS  Google Scholar 

  • Demarquay, G., Setiey, A., Morel, Y., Trepo, C., Chazot, G. and Broussolle, E. (2000) “Clinical report of three patients with hereditary hemochromatosis and movement disorders”, Mov. Disord. 15, 1204–1209.

    Article  PubMed  CAS  Google Scholar 

  • Dexter, D.T., Wells, F.R., Lees, A.J., Agid, F., Agid, Y., Jenner, P. and Marsden, C.D. (1989) “Increased nigral iron content and alterations in other metal ions occuring in brain in Parkinson’s disease”, J. Neurochem. 52, 1830–1836.

    Article  PubMed  CAS  Google Scholar 

  • Dexter, D.T., Jenner, P., Schapira, A.H.V. and Marsden, C.D. (1992) “Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia”, Ann. Neurol. 32, 94–100.

    Article  Google Scholar 

  • Dickson, D.W., Wen-Lang, L., Wan-Kyun, L. and Shu-Hui, Y. (1999) “Multiple system atrophy: a sporadic synucleinopathy”, Brain Pathol. 9, 721–732.

    Article  PubMed  CAS  Google Scholar 

  • Donovan, A., Brownlie, A., Zhou, Y., et al., (2000) “Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter”, Nature 403, 776–781.

    Article  PubMed  CAS  Google Scholar 

  • Dooling, E.C., Schoene, W.C. and Richardson, Jr., E.P. (1974) “Hallervorden-Spatz syndrome”, Arch. Neurol. 1974, 70–83.

    Google Scholar 

  • Double, K.L., Maywald, M., Schmittel, M., Riederer, P. and Gerlach, M. (1998) “In vitro studies of ferritin iron release and neurotoxicity”, J. Neurochem. 70, 2492–2499.

    Article  PubMed  CAS  Google Scholar 

  • Double, K.L., Riederer, P. and Gerlach, M. (1999) “Significance of neuromelanin for neurodegeneration in Parkinson’s disease”, Drug News Perspect. 12, 333–340.

    CAS  Google Scholar 

  • Drysdale, J.W. (1988) “Human ferritin gene expression”, Prog. Nucleic Acids Res. Mol. Biol. 35, 127–155.

    Article  CAS  Google Scholar 

  • Durr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.L., Brice, A. and Koenig, M. (1996) “Clinical and genetic abnormalities in Friedreich’s ataxia”, N. Engl. J. Med. 335, 1169–1175.

    Article  PubMed  CAS  Google Scholar 

  • Emond, M., Lepage, G., Vanasse, M. and Pandolfo, M. (2000) “Increased levels of plasma malondialdehyde in Friedreich ataxia”, Neurology 55, 1752–1753.

    PubMed  CAS  Google Scholar 

  • Faucheux, B.A., Nillesse, N., Damier, P., Spik, G., Mouatt-Prigent, A., Pierce, A., Leveugle, B., Kubis, N., Hauw, J.J., Agid, Y., et al., (1995) “Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson’s disease”, Proc. Natl. Acad. Sci. USA 92, 9603–9607.

    Article  PubMed  CAS  Google Scholar 

  • Fernandez Leite, J. (2001) “Huntington’s disease: a bimolecular vision”, Rev. Neurol. 32, 762–767.

    Google Scholar 

  • Fillebeen, C., Mitchell, V., Dexter, D., Benaissa, M., Beauvillain, J.C., Spik, G. and Pierce, A. (1999) “Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment”, Mol. Brain. Res. 72, 183–194.

    Article  PubMed  CAS  Google Scholar 

  • Foury, F. (1999) “Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain”, FEBS Lett. 456, 281–284.

    Article  PubMed  CAS  Google Scholar 

  • Foury, F. and Talibi, D. (2000) “Mitochondrial control of iron homeostasis: a genome wide analysis of gene expression in a yeast frataxin deficient mutant”, J. Biol. Chem. 276, 7762–7768.

    Article  PubMed  Google Scholar 

  • Gai, W.P., Power, J.H., Blumbergs, P.C. and Blessing, W.W. (1998) “Multiple-system atrophy: a new alpha-synuclein disease”, Lancet 352, 547–648.

    Article  PubMed  CAS  Google Scholar 

  • Galvin, J.E., Giasson, B., Hurtig, H.I., Lee, V.M. and Trojanowski, J.Q. (2000) “Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology”, Am. J. Pathol. 157, 361–368.

    PubMed  CAS  Google Scholar 

  • Gattermann, N., Aul, C. and Schneider, W. (1993) “Is acquired idiopathic sideroblastic anemia (AISA) a disorder of mitochondrial DNA?”, Leukemia 7, 2069–2076.

    PubMed  CAS  Google Scholar 

  • Gaudette, M., Hirano, M. and Siddique, T. (2000) “Current status of SOD1 mutations in amyotrophic lateral sclerosis”, Amyotrophic Lateral Sclerosis and Other Motoneuron Diseases 1, 83–90.

    Article  CAS  Google Scholar 

  • Gerlach, M., Ben-Shachar, D., Riederer, P. and Youdim, M.B. (1994) “Altered brain metabolism of iron as a cause of neurodegenerative diseases”, J. Neurochem. 63, 793–807.

    Article  PubMed  CAS  Google Scholar 

  • Gerlach, M., Reichmann, H. and Riederer, P. (2001) Die Parkinsonkrankheit, Grundlagen, Klinik, Therapie (Springer, Wien, NY).

    Google Scholar 

  • Girelli, D., Corrocher, R., Bisceglia, L., Olivieri, O., Zelante, L., Panozzo, G. and Gaspari, P. (1997) “Hereditary hyperferritinemia-cataract syndrome caused by a 29-base pair deletion in the iron responsive element of ferritin L-subunit gene”, Blood 90, 2084–2088.

    PubMed  CAS  Google Scholar 

  • Gitlin, J.D. (1998) “Aceruloplaminemia”, Pediatr. Res. 44, 271–276.

    Article  PubMed  CAS  Google Scholar 

  • Golts, N., Snyder, H., Frasier, M., Theisler, C., Choi, P. and Wolozin, B. (2002) “Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein. Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein”, J. Biol. Chem. 277, 16116–16123.

    Article  PubMed  CAS  Google Scholar 

  • Gordon, N. (2000) “Friedreich’s ataxia and iron metabolism”, Brain Dev. 22, 465–468.

    Article  PubMed  CAS  Google Scholar 

  • Gorell, J.M., Ordidge, R.J., Brown, G.G., Deniau, J.C., Buderer, N.M. and Helpern, J.A. (1995) “Increased iron-related MRI contrast in the substantia nigra in Parkinson’s disease”, Neurology 45, 1138–1143.

    PubMed  CAS  Google Scholar 

  • Götz, M., Künig, K., Riederer, P. and Youdim, M. (1994) “Oxidative stress: free radical production in neural degeneration”, Pharmacol. Ther. 63, 37–112.

    Article  PubMed  Google Scholar 

  • Griffiths, P.D., Dobson, B.R., Jones, G.R. and Clarke, D.T. (1999) “Iron in the basal ganglia in Parkinson’s disease. An in vitro study using extended X-ray absorption find structure and cryo-electron microscopy”, Brain 122, 667–673.

    Article  PubMed  Google Scholar 

  • Gruenheid, S., Canonne-Hergaux, F., Gauthier, S., Hackam, D.J., Grinstein, S. and Gros, P. (1999) “The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes”, J. Exp. Med. 189, 831–841.

    Article  PubMed  CAS  Google Scholar 

  • Gunshin, H., Mackenzie, B., Berger, U.V., Gunshin, Y., Romero, M.F., Boron, W.F., Nussberger, S., Gollan, J.L. and Hediger, M.A. (1997) “Cloning and characterisation of mammalian protoncoupled metal-ion transporter”, Nature 388, 482–488.

    Article  PubMed  CAS  Google Scholar 

  • Gutierrez, J.A., Yu, J., Rivera, S. and Wessling-Resnick, M. (1997) “Functional expression cloning and characterization of SFT, a stimulator of Fe transport”, J. Cell Biol. 139, 895–905.

    Article  PubMed  CAS  Google Scholar 

  • Gutierrez, J.A., Yu, J. and Wessling-Resnick, M. (1998) “Characterization and chromosomal mapping of the human gene for SFT, a stimulator of Fe transport”, Biochem. Biophys. Res. Commun. 253, 739–742.

    Article  PubMed  CAS  Google Scholar 

  • Haile, D.J. (1999) “Regulation of genes of iron metabolism by the iron-response proteins”, Am. J. Med. Sci. 318, 230–240.

    Article  PubMed  CAS  Google Scholar 

  • Hallgren, B. and Sourander, P. (1958) “The effect of age on non-haem iron in the human brain”, J. Neurochem. 3, 41–51.

    Article  PubMed  CAS  Google Scholar 

  • Halliday, W. (1995) “The nosology of Hallervorden-Spatz disease”, J. Neurol. Sci. 134, 84–91.

    Article  PubMed  Google Scholar 

  • Halliwell, B. (2001) “Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment”, Drugs Aging 18, 685–716.

    Article  PubMed  CAS  Google Scholar 

  • Harding, A.E. (1981) “Friedreich’s ataxia: a clinical a genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features”, Brain 104, 598–620.

    Article  Google Scholar 

  • Harris, Z.L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R.T. and Giltin, J.D. (1995) “Aceruloplasminemia: molecular characterization of this disorder of iron metabolism”, Proc. Natl Acad. Sci. USA 92, 2539–2543.

    Article  PubMed  CAS  Google Scholar 

  • Harris, Z.L., Durley, A.P., Man, T.K. and Giltin, J.D. (1999) “Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux”, Proc. Natl Acad. Sci. USA 96, 10812–10817.

    Article  PubMed  CAS  Google Scholar 

  • Harrison, P.M. and Arrosio, P. (1996) “The ferritin: molecular properties, iron storage function and cellular regulation”, Biochim. Biophys. Acta 1275, 161–203.

    Article  PubMed  Google Scholar 

  • Hashimoto, M., Hsu, L.J., Sisk, A., Xia, Y., Takeda, A., Sundsmo, M. and Masliah, E. (1998) “Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease”, Brain Res. 799, 301–306.

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto, M., Hsu, L.J., Xia, Y., Takeda, A., Sisk, A. and Masliah, E. (1999) “Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro”, NeuroReport 10, 717–721.

    Article  PubMed  CAS  Google Scholar 

  • Hellier, K.D., Hatchwell, E., Duncombe, A.S., Kew, J. and Hammans, S.R. (2001) “X-linked sideroblastic anemia with ataxia: another mitochondrial disease?”, J. Neurol. Neurosurg. Psychiatry 70, 65–69.

    Article  PubMed  CAS  Google Scholar 

  • Hellmann, N.E., Kono, S., Miyajima, H. and Gitlin, J.D. (2002) “Biochemical analysis of a missense mutation in aceruloplasminemia”, J. Biol. Chem. 277, 1375–1380.

    Article  CAS  Google Scholar 

  • Hentze, M.W. and Kuhn, L.C. (1996) “Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress”, Proc. Natl Acad. Sci. USA 93, 8175–8182.

    Article  PubMed  CAS  Google Scholar 

  • Hickman, S.J., Ward, N.S., Surtees, R.A.H., Stevens, J.M. and Farmer, S.F. (2001) “How broad is the phenotype of Hallervorden-Spatz disease”, Acta Neurol. Scand. 103, 201–203.

    Article  PubMed  CAS  Google Scholar 

  • Higgins, C.F. (1992) “ABC transporters: from microorganisms to man”, Annu. Rev. Cell. Biol. 8, 67–113.

    Article  PubMed  CAS  Google Scholar 

  • Hilditch-Maguire, P., Trettel, F., Passani, L.A., Auerbach, A., Persichetti, F. and MacDonald, M.E. (2000) “Huntingtin: a iron regulated protein essential for normal nuclear and perinuclear organelles”, Hum. Mol. Genet. 9, 2789–2797.

    Article  PubMed  CAS  Google Scholar 

  • Huntington’s Disease Collaborative Research Group (1993) “A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes”, Cell 72, 971–983.

    Article  Google Scholar 

  • Imon, Y., Yamaguchi, S., Yamamura, Y., Tsuji, S., Kajima, T., Ito, K. and Nakamura, S. (1995) “Low intensity areas observed on T2-weighted magnetic resonance imaging of the cerebral cortex in various neurological disorders”, J. Neurol. Sci. 134 (Suppl.), 27–32.

    Article  PubMed  Google Scholar 

  • Jefferies, W.A., Food, M.R., Gabathuler, R., Rothenberger, S., Yamada, T., Yasuhara, O. and McGeer, P.L. (1996) “Reactive microglia specifically associated with amyloid plaques in Alzheimer’s disease brain tissue express melanotransferrin”, Brain Res. 712, 122–126.

    Article  PubMed  CAS  Google Scholar 

  • Jellinger, K., Riederer, P. and Tomonaga, M. (1980) “Progressive supranuclear palys: clinicopathological and biochemical studies”, J. Neural Transm. Suppl. 16, 111–128.

    PubMed  Google Scholar 

  • Jellinger, K., Kienzl, E., Rumpelmaier, G., Riederer, P., Stachelberg, H., Ben-Shachar, D. and Youdim, M.B. (1992) “Iron-melanin complex in substantia nigra of Parkinsonian brains: an X-ray microanalysis”, J. Neurochem. 59, 1168–1171.

    Article  PubMed  CAS  Google Scholar 

  • Jellinger, K.A. (1999) “The role of iron in neurodegeneration”, Drugs Aging 14, 115–140.

    Article  PubMed  CAS  Google Scholar 

  • Jones, A.L. (1996) “The Huntington’s disease gene and its protein product”, In: Harper, P.S., ed, Huntington’s Disease, 2nd Ed. (W.B. Saunders Co., Philadelphia), pp. 293–316.

    Google Scholar 

  • Karthikeyan, G., Lewis, L.K. and Resnick, M.A. (2002) “The mitochondrial protein frataxin prevents nuclear damage”, Hum. Mol. Genet. 16, 1351–1362.

    Article  Google Scholar 

  • Kasarski, E.J., Tandon, L., Lovell, M.A. and Ehmann, W.D. (1995) “Aluminium, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study”, J. Neurol. Sci. 130, 203–208.

    Article  Google Scholar 

  • Kato, S., Nakamura, H., Hirano, A., Ito, H., Llena, J.F. and Yen, S.H. (1991) “Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy)”, Acta Neuropathol. (Berl.) 82, 488–493.

    Article  CAS  Google Scholar 

  • Kato, J., Fujikawa, K., Kanda, M., Fukuda, N., Sasaki, K., Takayama, T., Kobune, M., Takada, K., Takimoto, R., Hamada, H., Ikeda, T. and Niitsu, Y. (2001) “A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload”, Am. J. Hum. Genet. 69, 191–197.

    Article  PubMed  CAS  Google Scholar 

  • Kennard, M.L., Feldman, H., Yamada, T. and Jefferies, W.A. (1996) “Serum levels of the iron binding protein p97 are elevated in Alzheimer’s disease”, Nat. Med. 2, 1230–1235.

    Article  PubMed  CAS  Google Scholar 

  • Kim, D.K., Seo, M.Y., Lim, S.W., Kim, S., Kim, J.W., Carroll, B.J., Kwon, D.Y., Kwon, T. and Kang, S.S. (2001) “Serum melanotransferrin, p97 as a biochemical marker of Alzheimer’s disease”, Neuropsychopharmacology 25, 84–90.

    Article  PubMed  CAS  Google Scholar 

  • Kispal, G., Csere, P., Guiard, B. and Lill, R. (1997) “The ABC transporter Atm1p is required for mitochondrial iron homeostasis”, FEBS Lett. 418, 346–350.

    Article  PubMed  CAS  Google Scholar 

  • Kispal, G., Csere, P., Prohl, C. and Lill, R. (1999) “The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins”, EMBO J. 18, 3981–3989.

    Article  PubMed  CAS  Google Scholar 

  • Klomb, L.W. and Gitlin, J.D. (1996) “Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenetic model in aceruloplasminea”, Hum. Mol. Gen. 5, 1989–1996.

    Article  Google Scholar 

  • Knutson, M.D., Levy, J.E., Andrews, N.C. and Wessling-Resnick, M. (2001) “Expression of stimulator of Fe transport is not enhanced in Hfe knockout mice”, J. Nutr. 131, 1459–1464.

    PubMed  CAS  Google Scholar 

  • Koeppen, A.H. and Dickson, A.C. (2001) “Iron in Hallervorden-Spatz syndrome”, Pediatr. Neurol. 25, 148–155.

    Article  PubMed  CAS  Google Scholar 

  • Kohno, S., Miyajima, H. and Takahashi, Y. (1999) “Aceruloplasminemia with a novel mutation associated with parkinsonism”, Neurogenetics 2, 237–238.

    Article  Google Scholar 

  • Kohno, S., Miyajima, H., Takahashi, Y., Suzuki, H. and Hishida, A. (2000) “Defective electron transfer in complex I and IV in patients with aceruloplasminemia”, J. Neurol. Sci. 182, 57–60.

    Article  PubMed  CAS  Google Scholar 

  • Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. (1998) “Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease”, Nat. Genet. 18, 106–108.

    Article  PubMed  CAS  Google Scholar 

  • Lamarche, J.B., Cote, M. and Lemieux, B. (1980) “The cardiomyopathy of Friedreich’s ataxia morphological observations in 3 cases”, Can. J. Neurol. Sci. 7, 389–396.

    PubMed  CAS  Google Scholar 

  • Lasker, A.G., Zee, D.S., Hain, T.C., Folstein, S.E. and Singer, H.S. (1987) “Saccades in Huntingon’s disease: initiation defects and distractability”, Neurology 37, 364.

    PubMed  CAS  Google Scholar 

  • Leveugle, B., Spik, G., Perl, D.P., Bouras, C., Fillit, H.M. and Hof, P.R. (1994) “The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis”, Brain Res. 650, 20–31.

    Article  PubMed  CAS  Google Scholar 

  • Leveugle, B., Faucheux, B.A., Bouras, C., Nillesse, N., Spik, G., Hirsch, E.C., Agid, Y. and Hof, P.R. (1996) “Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson’s disease”, Acta Neuropathol. 91, 566–572.

    Article  PubMed  CAS  Google Scholar 

  • LeVine, S.M. (1997) “Iron deposits in multiple sclerosis and Alzheimer’s disease brains”, Brain Res. 760, 298–303.

    Article  PubMed  CAS  Google Scholar 

  • Levy, J.E., Jin, O., Fujiwara, Y., Kuo, F. and Andrews, N.C. (1999) “Transferrin receptor is necessary for development of erythorcytes and the nervous system”, Nat. Genet. 21, 396–399.

    Article  PubMed  CAS  Google Scholar 

  • Lodi, R., Hart, P.E., Rajagopalan, B., Taylor, D.J., Crilley, J.G., Bradley, J.L., Blamire, A.M., Manners, D., Styles, P., Schapira, A.H. and Cooper, J.M. (2001a) “Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich’s ataxia”, Ann. Neurol. 49, 590–596.

    Article  PubMed  CAS  Google Scholar 

  • Lodi, R., Taylor, D.J. and Schapira, A.H.V. (2001b) “Mitochondrial dysfunction in Friedreich’s ataxia”, Biol. Signals Recept. 10, 263–270.

    Article  PubMed  CAS  Google Scholar 

  • Loeffler, D.A., Le Witt, P.A., Juneau, P.L., Sima, A.A., Nguyen, H.U., DeMaggio, A.J., Brickman, C.M., Brewer, G.J., Dick, R.D., Troyer, M.D. and Kanaley, L. (1996) “Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders”, Brain. Res. 738, 265–274.

    Article  PubMed  CAS  Google Scholar 

  • Loeffler, D.A., Sima, A.A. and LeWitt, P.A. (2001) “Ceruloplasmin immunoreactivity in neurodegenerative disorders”, Free Radic. Res. 35, 111–118.

    Article  PubMed  CAS  Google Scholar 

  • Lopiano, L., Chiesa, M., Digilio, G., Giraudo, S., Bergamasco, B., Torre, E. and Fasano, M. (2000) “Q-band EPR investigations of neuromelanin in control and Parkinson’s disease patients”, Biochim. Biophys. Acta 1500, 306–312.

    PubMed  CAS  Google Scholar 

  • Loreal, O., Turlin, B., Pigeon, C., Moisan, A., Ropert, M., Morice, P., Gandon, Y., Jouanolle, A.M., Verin, M., Hider, R.C., Yoshida, K. and Brissot, P. (2002) “Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights”, J. Hepatol. 36, 851–856.

    Article  PubMed  CAS  Google Scholar 

  • Lutz, T., Westermann, B., Neupert, W. and Herrmann, J.M. (2001) “The mitochondrial proteins Ssq1 and Jac1 are required for the assembly of iron sulfur clusters in mitochondria”, J. Mol. Biol. 307, 815–825.

    Article  PubMed  CAS  Google Scholar 

  • Lynch, D.R., Farmer, J.M., Balcer, L.J. and Wilson, R.B. (2002) “Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy”, Arch. Neurol. 59, 743–747.

    Article  PubMed  Google Scholar 

  • Malecki, E.A., Devenyi, A.G., Beard, J.L. and Connor, J.R. (1999) “Existing and emerging mechanisms for transport of iron and manganese to the brain”, J. Neurosci. Res. 56, 113–122.

    PubMed  CAS  Google Scholar 

  • Mandel, S., Grunblatt, E. and Youdim, M. (2000) “cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson’s disease”, J. Neural Transm. Suppl. 60, 117–124.

    PubMed  Google Scholar 

  • Martin, J.B. and Gusella, J.F. (1986) “Huntington’s diease: pathogenesis and management”, N. Engl. J. Med. 315, 1267–1276.

    Article  PubMed  CAS  Google Scholar 

  • Martin, M.E., Fargion, S., Brissot, P., Pellat, B. and Beaumont, C. (1998a) “A point mutation in the bulge of the iron-responsive element of the L ferritin gene in two families with the hereditary hyperferritinemia-cataract syndrome”, Blood 91, 319–323.

    PubMed  CAS  Google Scholar 

  • Martin, W.R., Roberts, T.E., Ye, F.Q. and Allen, P.S. (1998) “Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance”, Can. J. Neurol. Sci. 25, 44–47.

    PubMed  CAS  Google Scholar 

  • McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T.J., Farzaneh, F., Hediger, M.A., Hentze, M.W. and Simpson, R.J. (2000) “A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation”, Mol. Cell 5, 299–309.

    Article  PubMed  CAS  Google Scholar 

  • Medrum, B. and Garthwaite, J. (1990) “Excitatory amino acid neurotoxicity and neurodegenerative disease”, Trends Pharmacol. Sci., 54–62, A TiPS special report.

  • Miyajima, H., Kohno, S., Takahashi, Y., Yonekawa, O. and Kanno, T. (1999) “Estimation of the gene frequency of aceruloplasminemia in Japan”, Neurology 53, 617–619.

    PubMed  CAS  Google Scholar 

  • Miyajima, H., Kohno, S., Takahashi, Y., Sugimoto, M., Sakamoto, M. and Skai, N. (2001) “Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation”, Neurology 26, 2205–2210.

    Google Scholar 

  • Mohanakumar, K.P., de Bartolomeis, A., Wu, R.M., Yeh, K.J., Sternberger, L.M., Peng, S.Y., Murphy, D.L. and Chiueh, C.C. (1994) “Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation”, Ann. N.Y. Acad. Sci. 738, 392–399.

    Article  PubMed  CAS  Google Scholar 

  • Moos, T. and Morgan, E.H. (1998) “Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid”, J. Neurosci. Res. 54, 468–494.

    Article  Google Scholar 

  • Moos, T. and Morgan, E.H. (2000) “Transferrin and transferrin receptor function in brain barrier systems”, Cell Mol. Neurobiol. 20, 77–95.

    Article  PubMed  CAS  Google Scholar 

  • Morita, H., Ikeda, S., Yamamoto, K., Morita, S., Yoshida, K., Nomoto, S., Kato, M. and Yanagisawa, N. (1995) “Hereditary ceruloplasmin deficiency with hemosiderosis: a clinico-pathological study of a Japanese familiy”, Ann. Neurol. 37, 646–656.

    Article  PubMed  CAS  Google Scholar 

  • Muhlenhoff, U. and Lill, R. (2000) “Biogenesis of iron-sulfur proteins in eukaryotes: a novel task of mitochondria that is inherited from bacteria”, Biochim. Biophys. Acta 1459, 370–382.

    Article  PubMed  CAS  Google Scholar 

  • Mukhopadhyay, C.K., Attieh, Z.K. and Fox, P.L. (1998) “Role of ceruloplasmin in cellular iron uptake”, Science 279, 714–717.

    Article  PubMed  CAS  Google Scholar 

  • Neumann, M., Adler, S., Schlüter, O., Kremmer, E., Benecke, R. and Kretzschmar, H.A. (2000) “α-Synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome). with widespread cortical and brainstem-type Lewy bodies”, Acta Neuropathol. 100, 568–574.

    Article  PubMed  CAS  Google Scholar 

  • Nielsen, J.E., Neerup Jensen, L. and Krabbe, B. (1995) “Heredita haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome”, J. Neurol. Neurosurg. Psychiatry 59, 318–578.

    Article  PubMed  CAS  Google Scholar 

  • Oba, H., Araki, T., Ohtomo, K., Monzawa, S., Uchiyama, G., Koizumi, K., Nogata, Y., Kachi, K., Shiozawa, Z. and Kobayashi, M. (1993) “Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging”, Radiology 189, 843–846.

    PubMed  CAS  Google Scholar 

  • Obata, T. (2002) “Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping”, Toxicol. Lett. 132, 83–93.

    Article  PubMed  CAS  Google Scholar 

  • Oeda, T., Shimohama, S., Kitagawa, N., Kohno, R., Imura, T., Shibasaki, H. and Ishii, N. (2001) “Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans”, Hum. Mol. Genet. 15, 2013–2023.

    Article  Google Scholar 

  • Okamato, N., Wada, S., Oga, T., Kawabata, Y., Baba, Y., Habu, D., Takeda, Z. and Wada, Y. (1996) “Hereditary ceruloplasmin deficiency with hemosiderosis”, Hum. Genet. 97, 755–758.

    Article  Google Scholar 

  • Olanow, C.W. (1992) “Magnetic resonance imaging in parkinsonism”, Neurol. Clin. 10, 405–420.

    PubMed  CAS  Google Scholar 

  • Olney, J.W., Ho, O.L. and Rhee, V. (1971) “Cytotoxic effect of acidic and sulfur containing amino acids on the infant mouse central nervous system”, Exp. Brain Res. 14, 61–76.

    Article  PubMed  CAS  Google Scholar 

  • Olsen, M.K., Roberds, S.L., Ellerbrock, B.R., Fleck, T.J., McKinley, D.K. and Gurney, M.E. (2001) “Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord”, Ann. Neurol. 50, 730–740.

    Article  PubMed  CAS  Google Scholar 

  • Oskai, S., Johnson, D.A. and Frieden, E. (1966) “The possible role of the ferrous oxidase activity of ceruloplasmin in normal human serum”, J. Biol. Chem. 241, 11490–11491.

    Google Scholar 

  • Ostergaard, J.R., Christensen, T. and Hansen, K.N. (1995) “In vivo diagnosis of Hallervorden-Spatz disease”, Dev. Med. Child. Neurol. 37, 827–833.

    Article  PubMed  CAS  Google Scholar 

  • Osterova-Golts, N., Petrucelli, L., Hardy, J., Lee, J.M., Farer, M. and Wolozin, B. (2000) “The A53T α-synuclein mutation increases iron dependent aggregation and toxicity”, J. Neurosci. 20, 6048–6054.

    Google Scholar 

  • Pagon, R.A., Bird, T.D., Detter, J.C. and Pierce, I. (1985) “Hereditary sideroblastic anaemia and ataxia: an X-linked recessive disorder”, J. Med. Genet. 22, 267–273.

    Article  PubMed  CAS  Google Scholar 

  • Paik, S., Shin, H., Lee, J., Chang, C. and Kim, J. (1999) “Copper(II)-induced self oligomerization of α-synuclein”, Biochem. J. 340, 821–828.

    Article  PubMed  CAS  Google Scholar 

  • Park, L.C., Albers, D.S., Xu, H., Lindsay, J.G., Beal, M.F. and Gibson, G.E. (2001) “Mitochondrial impairment in the cerebellum of the patients with progressive supranuclear palsy”, J. Neurosci. Res. 66, 1028–1034.

    Article  PubMed  CAS  Google Scholar 

  • Patel, I.P. and Isaya, G. (2001) “Freidreich ataxia: from GAA tripletrepeat expansion to frataxin deficiency”, Am. J. Hum. Genet. 69, 15–24.

    Article  PubMed  CAS  Google Scholar 

  • Patel, B.N., Dunn, R.J. and David, S. (2000) “Alternative RNA splicing generates a glycosylphosphtidylinositol-anchored form of ceruloplasmin in mammalian brain”, J. Biol. Chem. 275, 4305–4310.

    Article  PubMed  CAS  Google Scholar 

  • Paxinos, G., ed, (1990) The Human Nervous System (Academic Press, San Diego, CA).

    Google Scholar 

  • Perez, M., Valpuesta, J.M., Montejo de Garcini, E. and Avila, J. (1998) “Ferritin is associated with the aberrant tau filaments in preogressive supranuclear palsy”, Am. J. Pathol. 152, 1531–1539.

    PubMed  CAS  Google Scholar 

  • Perry, T.L., Norman, M.G., Yong, V.W., Whiting, S., Crichton, J.U., Hansen, S. and Kish, S.J. (1985) “Hallervorden-Spatz disease: cystein accumulation and cystein dioxygenase deficiency in the globus pallidus”, Ann. Neurol. 18, 482–489.

    Article  PubMed  CAS  Google Scholar 

  • Piemonte, F., Pastore, A., Tozzi, G., Tagliacozzi, D., Santorelli, F.M., Carrozzo, R., Casali, C., Damiano, M., Federici, G. and Bertini, E. (2001) “Glutathione in blood of patients with Friedreich’s ataxia”, Eur. J. Clin. Investig. 31, 1007–1011.

    Article  CAS  Google Scholar 

  • Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., Di Iorio, G., Golbe, L.I. and Nussbaum, R.L. (1997) “Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease”, Science 276, 2045–2047.

    Article  PubMed  CAS  Google Scholar 

  • Ponka, P. (1999) “Cellular iron metabolism”, Kidney Int. 55 (Suppl. 69), 2–11.

    Article  Google Scholar 

  • Pook, M.A., Al Mahdawi, S.A., Thomas, N.H., Appleton, R., Norman, A., Mountford, R. and Chamberlain, S. (2000) “Identification of three novel frameshift mutations in patients with Friedreich’s ataxia”, J. Med. Genet. 37, E38.

    Article  PubMed  CAS  Google Scholar 

  • Powell, H.C., London, G.W. and Lampert, P.W. (1974) “Neurofibrillary tangles in progressive supranuclear palsy: electron microscopic observations”, J. Neuropathol. Exp. Neurol. 33, 98–106.

    Article  PubMed  CAS  Google Scholar 

  • Qian, Z.M. and Ke, Y. (2001) “Rethinking the role of ceruloplasmin in brain iron metabolism”, Brain Res. Rev. 35, 287–294.

    Article  PubMed  CAS  Google Scholar 

  • Qian, Z.M. and Shen, X. (2001) “Brain iron transport and neurodegeneration”, Trends Mol. Med. 7, 103–108.

    Article  PubMed  CAS  Google Scholar 

  • Qian, Z.M. and Wang, Q. (1998) “Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders”, Brain Res. Rev. 27, 257–267.

    Article  PubMed  CAS  Google Scholar 

  • Racette, B.A., Perry, A., D’Avossa, G. and Perlmutter, J.S. (2001) “Late-onset neurodegeneration with brain iron accumulation type 1: expanding the clinical spectrum”, Mov. Disord. 16, 1148–1152.

    Article  PubMed  CAS  Google Scholar 

  • Radisky, D.C., Bacock, M.C. and Kaplan, J. (1999) “The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondrial iron cycle”, J. Biol. Chem. 274, 4497–4499.

    Article  PubMed  CAS  Google Scholar 

  • Raskind, W.H., Wijsman, E., Pagon, R.A., Cox, T.C., Bawden, M.J., May, B.K. and Bird, T.D. (1991) “X-linked sideroblastic anemia and ataxia: linkage to phosphoglycerate kinase a Xq13”, Am. J. Hum. Genet. 48, 335–341.

    PubMed  CAS  Google Scholar 

  • Reilly, C.A. and Aust, S.D. (1997) “Stimulation of the ferroxidase activity of ceruloplasmin during the iron loading into ferritin”, Arch. Biochem. Biophys. 347, 242–248.

    Article  PubMed  CAS  Google Scholar 

  • Riederer, P., Sofic, E., Rausch, W.D., Kruzik, P. and Youdim, M.B.H. (1985) “Dopaminforschung heute und morgen—L-Dopa in der Zukunft”, In: Riederer, P. and Umek, H., eds, L-Dopa-Substitution der Parkinsonkrankheit, Geschichte-Gegenwart-Zukunft (Springer, Wien, NY), pp. 127–144.

    Google Scholar 

  • Riederer, P., Sofic, E., Rausch, W.D., Schmidt, B., Reynolds, G.P., Jeellinger, K. and Youdim, M.B.H. (1989) “Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains”, J. Neurochem. 52, 515–520.

    Article  PubMed  CAS  Google Scholar 

  • Riederer, P., Dirr, A., Goetz, M., Sofic, E., Jellinger, K. and Youdim, M.B. (1992) “Distribution of iron in different brain regions and subcellular compartments in Parkinson’s disease”, Ann. Neurol. 32, 101–104.

    Article  Google Scholar 

  • Rock, C.O., Calder, R.B., Karim, M.A. and Jackowski, S. (2000) “Pantothenate kinase regulation of the intracellular concentration of coenzym A”, J. Biol. Chem. 14, 1377–1383.

    Article  Google Scholar 

  • Rosen, R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O’Regan, J.P., Deng, H.X., et al., (1993) “Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis”, Nature 362, 59–62.

    Article  PubMed  CAS  Google Scholar 

  • Rotig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A. and Rustin, P. (1997) “Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia”, Nat. Genet. 17, 215–217.

    Article  PubMed  CAS  Google Scholar 

  • Rouault, T. (2001) “Systemic iron metabolism: a review and implications for brain iron metabolism”, Pediatr. Neurol. 25, 130–137.

    Article  PubMed  CAS  Google Scholar 

  • Rustin, P., VonKleist-Retzow, J.C., Chantrel-Goussard, K., Sidi, D., Munnich, A. and Rotig, A. (1999) “Effect of idebenone on cardiomyopathy in Friedreich’s ataxia: a preliminary study”, Lancet 354, 477–479.

    Article  PubMed  CAS  Google Scholar 

  • Rutledge, J.N., Hilal, S.K., Silver, A.J., Defendini, R. and Fahn, S. (1987) “Study of movement disorders and brain iron by MR”, AJNR 8, 397–411.

    Google Scholar 

  • Ryvlin, P., Broussolle, E., Piollet, H., Viallet, F., Khalfallah, Y. and Chazot, G. (1995) “Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson’s disease”, Arch. Neurol. 52, 583–588.

    PubMed  CAS  Google Scholar 

  • Sampieto, M., Caputo, L., Casatta, A., Meregalli, M., Pellagatti, A., Tagliabue, J., Annoni, G. and Vergani, C. (2001) “The hemochromatosis gene affects the age of onset of sporadic Alzheimer’s disease”, Neurobiol. Aging 22, 563–568.

    Article  Google Scholar 

  • Savoiardo, M., Halliday, W.C., Nardocci, N., Strada, L., D’Incerti, L., Angelini, L., Rumi, V. and Tesoro-Tess, J.D. (1993) “Hallervorden-Spatz disease. MR and pathologic findings”, Am. J. Neuroradiol. 14, 155–162.

    PubMed  CAS  Google Scholar 

  • Savoreido, M., Girotti, F., Strada, L. and Ciceri, E. (1994) “Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders”, J. Neural Transm. Suppl. 42, 93–110.

    Google Scholar 

  • Sayre, L.M., Zelasko, D.A., Harris, P.L.R., Perry, G., Salomon, R.G. and Smith, M.A. (1997) “4-Hydroxynonenal-derived advanced lipid peroxidation end products increased in Alzheimer’s disease”, J. Neurochem. 68, 2092–2097.

    Article  PubMed  CAS  Google Scholar 

  • Sayre, L.M., Perry, G. and Smith, M.A. (1999) “Redox metals and neurodegenerative diseases”, Curr. Opin. Chem. Biol. 3, 220–225.

    Article  PubMed  CAS  Google Scholar 

  • Sayre, L.M., Perry, G., Harris, P.L., Liu, Y., Schubert, K.A. and Smith, M.A. (2000) “In situ oxidative calalysis by neurofibrillary tangles and senile palques in Alzheimer’s disease: a central role for bound transition metals”, J. Neurochem. 74, 270–279.

    Article  PubMed  CAS  Google Scholar 

  • Schipper, H.M. (2000) “Heme oxygenase-1: role in brain aging and neurodegeneration”, Exp. Gerontol. 35, 821–830.

    Article  PubMed  CAS  Google Scholar 

  • Senbongi, H., Ling, F. and Shibata, T. (1999) “A mutation in a mitochondrial ABC transporter results in mitochondrial dysfunction through oxidative damage of mitochondrial DNA”, Mol. Gen. Genet. 262, 426–436.

    Article  PubMed  CAS  Google Scholar 

  • Sheth, S. and Briitenham, G.M. (2000) “Geneticdisorders affecting proteins of iron metabolism: clinical implications”, Ann. Rev. Med. 51, 443–464.

    Article  PubMed  CAS  Google Scholar 

  • Shimada, Y., Okuno, S., Kawai, A., Shinomiya, H., Saito, A., Suzuki, M., Omori, Y., Nishino, N., Kanemoto, N., Fujiwara, T., Horie, M. and Takahashi, E. (1998) “Cloning an chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia”, J. Hum. Genet. 43, 115–122.

    Article  PubMed  CAS  Google Scholar 

  • Shoham, S. and Youdim, M.B. (2000) “Iron involvement in neural damage and microgliosis in models of neurodegerative disorders”, Cell Mol. Biol. 46, 743–760.

    PubMed  CAS  Google Scholar 

  • Smith, M.A., Harris, P.L.R., Sayre, L.M., Beckmann, J.S. and Perry, G. (1997) “Widespread peroxynitrite-mediated damage in Alzheimer’s disease”, J. Neurosci. 17, 2653–2657.

    PubMed  CAS  Google Scholar 

  • Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G.P., Hebenstreit, G. and Youdim, M.B. (1988) “Increased iron (III). and total iron content in post mortem substantia nigra of parkinsonian brain”, J. Neural. Transm. 74, 199–205.

    Article  PubMed  CAS  Google Scholar 

  • Spillantini, M.G., Crowther, R.A., Jakes, R., Cairns, N.J., Lantos, P.L. and Goedert, M. (1998) “Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson’s disease and dementia with Lewy bodies”, Neurosci. Lett. 251, 205–208.

    Article  PubMed  CAS  Google Scholar 

  • Swaiman, K.F. (1991) “Hallervorden-Spatz syndrome and brain iron metabolism”, Arch. Neurol. 48, 1285–1293.

    PubMed  CAS  Google Scholar 

  • Swaiman, K.F. (2001) “Hallervorden-Spatz syndrome”, Pediatr. Neurol. 25, 102–108.

    Article  PubMed  CAS  Google Scholar 

  • Swaiman, K.F., Smith, S.A., Trock, G.L. and Siddiqui A.R. (1983) “Sea-blue histiocytes, lymphocytic cytosomes, and 59Fe-studies in Hallervorden-Spatz syndrome”, Neurology 33, 301–305.

    PubMed  CAS  Google Scholar 

  • Tabucchi, M., Yoshimori, T., Yamaguchi, K., Yoshida, T. and Kishi, F. (2000) “Human NRAMP2/DMT1, which mediates iron transport across endosomal membranes, is localized to late endosomes and lysosomes in Hep-2 cells”, J. Biol. Chem. 21, 22220–22228.

    Article  Google Scholar 

  • Taylor, T.D., Litt, M., Kramer, P., Pandolfo, M., Angelini, L., Nardocci, N., Davis, S., Pineda, M., Hattori, H., Flett, P.J., Cilio, M.R., Bertini, E. and Hayflick, S.J. (1996) “Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3–p13”, Nat. Genet. 14, 479–481.

    Article  PubMed  CAS  Google Scholar 

  • Telenius, H., Kremer, H.P.H., Theilmann, J., Andrew, S.E., Almqvist, E., Anvret, M., Greenberg, C., Greenberg, J., Lucotte, G., Squitieri, F., et al., (1993) “Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent”, Hum. Mol. Genet. 4, 1535–1540.

    Article  Google Scholar 

  • Theil, E.C. (1987) “Ferritin; structure, gene regulation, and cellular function in animals, plants and microorganisms”, Annu. Rev. Biochem. 56, 289–315.

    Article  PubMed  CAS  Google Scholar 

  • Theil, E.C. (2000) “Targeting mRNA to regulate iron and oxygen metabolism”, Biochem. Pharmacol. 59, 87–93.

    Article  PubMed  CAS  Google Scholar 

  • Troncoso, J.C., Costello, A., Watson, A.L. Jr. and Johnson, G.V. (1993) “In vitro polymerization of oxidized tau into filaments”, Brain Res. 613, 313–316.

    Article  PubMed  CAS  Google Scholar 

  • Vulpe, C.D., Kuo, Y.M., Murphy, L., Cowley, L., Askwith, C., Libina, N., Gitschier, J. and Anderson, G.J. (1999) “Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse”, Nat. Genet. 21, 195–199.

    Article  PubMed  CAS  Google Scholar 

  • Vymazal, J., Righini, A., Brooks, R.A., Canesi, M., Mariani, C., Leonardi, M. and Pezzoli, G. (1999) “T1 and T2 in the brain of healthy subjects, patients with Pakinson disease and patients with multiple system atrophy: relation to iron content”, Radiology 211, 489–495.

    PubMed  CAS  Google Scholar 

  • Waldvogel, D., van Gelderen, M. and Hallett, M. (1999) “Increased iron content in the dentate nucleus of patients with Friedreich’s ataxia”, Ann. Neurol. 46, 123–135.

    Article  PubMed  CAS  Google Scholar 

  • Whetsell, W.O. (1996) “Current concept of excitotoxicity”, J. Neuropathol. Exp. Neurol. 55, 1–13.

    Article  PubMed  CAS  Google Scholar 

  • Wilson, R.B., Lynch, D.R. and Fischbeck, K.H. (1998) “Normal serum iron and ferritin concentrations in patients with Friedreich’s ataxia”, Ann. Neurol. 44, 132–134.

    Article  PubMed  CAS  Google Scholar 

  • Wilson, R.B., Lynch, D.R., Farmer, J.M., Brooks, D.G. and Fischbeck, K.H. (2000) “Increased serum transferrin receptor concentrations in Friedreich ataxia”, Ann. Neurol. 47, 659–661.

    Article  PubMed  CAS  Google Scholar 

  • Witte, D., Crosby, W., Edwards, C., Fairbanks, V. and Mitros, F. (1996) “Hereditary hemochromatosis”, Clin. Chim. Acta 245, 139–200.

    Article  PubMed  CAS  Google Scholar 

  • Yamada, T., Tsujioka, Y., Taguchi, J., Takahashi, M., Tsuboi, Y., Moroo, I., Yang, J. and Jefferies, W.A. (1999) “Melanotransferrin is produced by senile plaque-associated reactive microglia in Alzheimer’s disease”, Brain Res. 845, 1–5.

    Article  PubMed  CAS  Google Scholar 

  • Yang, F., Naylor, S.L., Lum, J.B., Cutshaw, S., McCombs, J.L., Naberhaus, K.H., McGill, J.R., Adrian, G.S., Moore, C.M., Barnett, D.R. and Bowman, B.H. (1986) “Characterization, mapping, and expression of the human ceruloplasmin gene”, Proc. Natl Acad. Sci. USA 83, 3257–3261.

    Article  PubMed  CAS  Google Scholar 

  • Yasui, M., Ota, K. and Garruto, R.M. (1993) “Concentration of zinc and iron in the brains of Guamanian patients with amytrophic lateral sclerosis and parkinsonism-demetia”, Neurotoxicology 14, 445–450.

    PubMed  CAS  Google Scholar 

  • Yoon, S.J., Koh, Y.H., Floyd, R.A. and Park, J.W. (2000) “Copper, zinc superoxide dismutase enhances DNA damage and mutagenicity induced by cystein/iron”, Mutat. Res. 448, 97–104.

    PubMed  CAS  Google Scholar 

  • Yoshida, T., Tanaka, M., Sotomatsu, A. and Hirai, S. (1995) “Activated microglia cause superoxide-mediated release of iron from ferritin”, Neurosci. Lett. 190, 21–24.

    Article  PubMed  CAS  Google Scholar 

  • Yoshida, K., Kaneko, K., Miyajima, H., Tokuda, T., Nakamura, A., Kato, M. and Ikeda, S.-I. (2000) “Increased lipid peroxidation in the brains of aceruloplasminemia patients”, J. Neurol. Sci. 175, 91–95.

    Article  PubMed  CAS  Google Scholar 

  • Youdim, M., Ben-Shachar, D. and Riederer, P. (1991) “Iron in brain function and dysfunction with emphasis on Parkinson’s disease”, Eur. Neurol. 31, 34–40.

    Article  PubMed  Google Scholar 

  • Youdim, M.B. and Riederer, P. (1997) “Understanding Parkinson’s disease”, Sci. Am. 276, 52–59.

    Article  PubMed  CAS  Google Scholar 

  • Young, S.P., Fahmy, M. and Golding, S. (1997) “Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells”, FEBS Lett. 411, 93–96.

    Article  PubMed  CAS  Google Scholar 

  • Zecca, L., Shima, T., Stroppolo, A., Goj, C., Battistron, G.A., Gerbasi, R., Sarna, T. and Swartz, H.M. (1996) “Interaction of neuromelanin and iron in the substantia nigra and other areas of human brain”, Neuroscience 73, 407–415.

    Article  PubMed  CAS  Google Scholar 

  • Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A.X., Gerlach, M., Riederer, P., Vezzoni, P. and Tampellini, D. (2001) “Iron, neuromelanin and ferritin in substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes”, J. Neurochem. 76, 1766–1773.

    Article  PubMed  CAS  Google Scholar 

  • Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M. and Sonnino, S. (2000) “Interaction of human substantia nigra neuromelanin with lipids and peptides”, J. Neurochem. 74, 1758–1765.

    Article  PubMed  CAS  Google Scholar 

  • Zecca, L., Fariello, R., Riederer, P., Sulzer, D., Gatti, A. and Tampellini, D. (2002) “The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson’s disease”, FEBS Lett. 510, 216–220.

    Article  PubMed  CAS  Google Scholar 

  • Zhou, B., Westaway, S.K., Levinson, B., Johnson, M.A., Gitschier, J. and Hayflick, S.J. (2001) “A novel pantothenate kinase gene (PANK2). is defective in Hallervorden-Spatz syndrome”, Nat. Genet. 28, 345–349.

    Article  PubMed  CAS  Google Scholar 

  • Zupanc, M.L., Chun, R.W.M. and Gilbert-Barness, E.F. (1990) “Osmiophilic deposits in cytosomes in Hallervorden-Spatz syndrome”, Pediatr. Neurol. 6, 345–352.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Bayerische Julius-Maximilians-Universität Würzburg, Josef-Schneider-Str. 11, D-97080, Würzburg, Germany

    D. Berg

  2. Center of Excellence for Parkinson’s disease of the National Foundation, Miami, USA

    D. Berg & P. Riederer

  3. Department of Neurology, University of the Saarland, Homburg, Saar, Germany

    G. Becker

  4. Clinical Neurochemistry, Department of Psychiatry and Psychotherapy, Bayerische Julius-Maximilians-Universität Würzburg, Würzburg, Germany

    P. Riederer

  5. Department of Human Genetics, University of Tübingen, Tübingen, Germany

    O. Rieß

Authors
  1. D. Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Riederer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Rieß
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Berg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berg, D., Becker, G., Riederer, P. et al. Iron in neurodegenerative disorders. neurotox res 4, 637–653 (2002). https://doi.org/10.1080/1029842021000045444

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/1029842021000045444

Keywords

Search

Navigation